People vaccinated against Covid-19 abroad with Chinese vaccines will now be able to benefit from the health pass in France, on the condition, however, of receiving an additional dose of Pfizer or Moderna, the government has decided.
But at the global level, the WHO recognizes others: the Chinese vaccines Sinopharm and Sinovac, as well as versions of the AstraZeneca vaccine which are equivalent to it but are manufactured outside the European Union (like the Indian Covishield vaccine). The Russian vaccine Sputnik V is not yet recognized by the EU or the WHO.
Until now, people vaccinated with Chinese vaccines, which require two doses, could not obtain a health pass in France without going through a full vaccination with one of the recognized vaccines. From now on, a third dose of mRNA vaccine will suffice.
It will have to be made “at least four weeks after the last injection carried out abroad”, specified the General Directorate of Health (DGS) in a note intended for caregivers.
To be able to benefit from this third dose, these people “will have to present paper or digital proof of their complete vaccination (that is to say of each injection carried out abroad)”.
If they have had only one dose of Chinese vaccine, they “will have to receive two doses of mRNA vaccine in order to complete their vaccination schedule and thus obtain their health pass in France”, underlines the DGS.
People vaccinated with two doses of one of the AstraZeneca versions manufactured for the extra-European market could already obtain their health pass “through the portal + French from abroad + or the portal + Tourist +” of the Ministry of Foreign Affairs. , recalls the DGS.
.
